Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells

Carbohydrate Polymers

Volumn 93, Issue 2, 2013, Pages 661-669

  Maya, S ^a   Kumar, Lekshmi G ^a   Sarmento, Bruno ^b,c,d   Sanoj Rejinold, N ^a   Menon, Deepthy ^a   Nair, Shantikumar V ^a   Jayakumar, R ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

^d INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

Author keywords

Cancer nanomedicine; Carboxymethyl chitosan nanoparticles; Cetuximab; EGFR; Paclitaxel; Targeted drug delivery

Indexed keywords

CARBOXYMETHYL CHITOSAN; CETUXIMAB; EGFR; PACLITAXEL; TARGETED DRUG DELIVERY;

CELL DEATH; CHITOSAN; DRUG DELIVERY; FLOW CYTOMETRY; GELATION; MEDICAL NANOTECHNOLOGY; MONOCLONAL ANTIBODIES; ONCOLOGY;

NANOPARTICLES;

ANTINEOPLASTIC AGENT; CETUXIMAB; CHITOSAN; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; NANOPARTICLE; O CARBOXYMETHYLCHITOSAN; O-CARBOXYMETHYLCHITOSAN; OXAZINE DERIVATIVE; RESAZURIN; TUMOR MARKER; XANTHENE DERIVATIVE;

ARTICLE; CELL DEATH; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SCREENING; ERYTHROCYTE; HEMOLYSIS; HUMAN; METABOLISM; METHODOLOGY; NANOTECHNOLOGY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; ERYTHROCYTES; HEMOLYSIS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NANOTECHNOLOGY; OXAZINES; PARTICLE SIZE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL; XANTHENES;

EID: 84874136100     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2012.12.032     Document Type: Article

References (41)

1. M. Agüeros, V. Zabaleta, S. Espuelas, M.A. Campanero, and J.M. Irache Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles Journal of Controlled Release 145 2010 2 8
2. A. Anitha, K.P. Chennazhi, S.V. Nair, and R. Jayakumar 5-Flourouracil loaded N, O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer Journal of Biomedical Nanotechnology 8 2012 1 14
3. A. Anitha, V.V. Divyarani, R. Krishna, V. Sreeja, N. Selvamurugan, and S.V. Nair Synthesis, characterization, cytotoxicity and antibacterial studies of chitosan, O-carboxymethyl and N, O-carboxymethyl chitosan nanoparticles Carbohydrate Polymers 78 2009 672 677
4. A. Anitha, S. Maya, N. Deepa, K.P. Chennazhi, H. Tamura, and S.V. Nair Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells Carbohydrate Polymers 83 2011 452 461
5. L.M. Bareford, and P.W. Swaan Endocytic mechanisms for targeted drug delivery Advanced Drug Delivery Reviews 59 2007 748 758
6. J.A. Barnard, J. Beauchamp, W.E. Russell, R.N. DuBois, and R.J. Coffey Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology Gastroenterology 108 1995 564 580
7. S.R. Benhabbour, J.C. Luft, D. Kim, A. Jain, S. Wadhwa, and M.C. Parrott In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel heptameric ZEGFR domain Journal of Controlled Release 158 2012 63 71
8. H.M. Courrier, N. Butz, and T.F. Vandamme Pulmonary drug delivery systems: Recent developments and prospects Critical Reviews in Therapeutic Drug Carrier Systems 19 2002 425 498
9. C.R. Dass, and T. Su Particle-mediated intravascular delivery of oligonucleotides to tumors: Associated biology and lessons from genotherapy Drug Delivery 8 2001 191 213
10. V.G. Deepagan, B. Sarmento, D. Menon, A. Nascimento, A. Jayasree, and M. Sreeranganathan In vitro targeted imaging and delivery of camptothecin using cetuximab conjugated multifunctional PLGA-ZnS nanoparticles Nanomedicine 7 2012 507 519
11. P.K. Dutta, and J. Dey Drug solubilization by amino acid based polymeric nanoparticles: Characterization and biocompatibility studies International Journal of Pharmaceutics 421 2011 353 363
12. H. Gareth Nanostructure-mediated drug delivery Nanomedicine: Nanotechnology Biology and Medicine 1 2005 22 30
13. W.J. Gullick Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers British Medical Bulletin 47 1991 87 98
14. V.K. Gupta, P.K. Karar, S. Ramesh, S.P. Misra, and A. Gupta Nanoparticle formulation for hydrophilic & hydrophobic drugs International Journal of Research in Pharmaceutical Sciences 1 2010 163 169
15. Z. Huang, Y. Tang, X. Zhou, Y. Zhou, D. Jin, and Y. Li Magnetic micelles as a potential platform for dual targeted drug delivery in cancer therapy International Journal of Pharmaceutics 429 2012 113 122
16. R. Jayakumar, M. Prabaharan, S.V. Nair, S. Tokura, H. Tamura, and N. Selvamurugan Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical applications Progress in Materials Science 55 2010 675 709
17. H. Jin, J.F. Lovell, J. Chen, K. Ng, W. Cao, and L. Ding Investigating the specific uptake of EGF-conjugated nanoparticles in lung cancer cells using fluorescence imaging Cancer Nanotechnology 1 2010 71 78
18. P. Kirkpatrick, J. Graham, and M. Muhsin Cetuximab Nature Reviews Drug Discovery 3 2004 549 550
19. V.K. Lakshmanan, K.S. Snima, J.D. Bumgardner, S.V. Nair, and R. Jayakumar Chitosan based nanoparticles in cancer therapy Advances in Polymer Science 243 2011 55 91
20. D.A. LaVan, D.M. Lynn, and R. Langer Moving smaller in drug discovery and delivery Nature Reviews Drug Discovery 1 2002 77 84
21. D.A. LaVan, T. McGuire, and R. Langer Small-scale systems for in vivo drug delivery Nature Biotechnology 21 2003 1184 1191
22. H. Lee, H. Fonge, B. Hoang, R.M. Reilly, and C. Allen The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles Molecular Pharmaceutics 7 2010 1195 1208
23. F. Li, J. Li, X. Wen, S. Zhou, X. Tong, and P. Su Anti-tumor activity of paclitaxel-loaded chitosan nanoparticles: An in vitro study Materials Science and Engineering: C 29 2009 2392 2397
24. S. Li, K.R. Schmitz, D.J. Philip, J.W. Jed, Wiltzius, and P. Kussie Structural basis for inhibition of the epidermal growth factor receptor by cetuximab Cancer Cell 7 2005 301 311
25. C. Liao, Q. Sun, B. Liang, J. Shen, and X. Shuai Targeting EGFR-over expressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide European Journal of Radiology 80 2011 699 705
26. K. Löw, M. Wacker, S. Wagner, K. Langer, and H. von Briesen Targeted human serum albumin nanoparticles for specific uptake in EGFR-expressing colon carcinoma cells Nanomedicine 7 2011 454 463
27. D.G. Marciniak, L. Moragoda, R.M. Mohammad, Y. Yu, K.K. Nagothu, and A. Aboukameel Epidermal growth factor receptor-related protein: A potential therapeutic agent for colorectal cancer Gastroenterology 124 2003 1337 1347
28. S. Maya, S. Indulekha, V. Sukhithasri, K.T. Smitha, S.V. Nair, and R. Jayakumar Efficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus International Journal of Biological Macromolecules 51 2012 392 399
29. F.M. Mickler, L. Mockl, N. Ruthardt, M. Ogris, E. Wagner, and C. Brauchle Tuning nanoparticle uptake: Live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand Nano Letters 12 2012 3417 3423
30. L. Pei-Chin, and L. Chien-Hui Cell cycle specific induction of apoptosis and necrosis by paclitaxel in the leukemic U937 cells Life Sciences 76 2005 1623 1639
31. R. Pirker, and M. Filipits Monoclonal antibodies against EGFR in non-small cell lung cancer Critical Reviews in Oncology/Hematology 80 2010 1 9
32. M. Prabaharan, R.L. Reis, and J. Mano Carboxymethyl chitosan-graft- phosphatidylethanolamine: Amphiphilic matrices for controlled drug delivery Reactive and Functional Polymers 67 2007 43 52
33. M.N.V. Ravi Kumar, R.A.A. Muzzarelli, C. Muzzarelli, H. Sashiwa, and A.J. Domb Chitosan chemistry and pharmaceutical perspectives Chemical Reviews 104 2004 6017 6084
34. A. Reid, L. Vidal, H. Shaw, and J. Bono Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu) European Journal of Cancer 43 2007 481 489
35. R.N. Sanoj, M. Muthunarayanan, V.V. Divyarani, P.R. Sreerekha, K.P. Chennazhi, and S.V. Nair Curcumin-loaded biocompatible thermo-responsive polymeric nanoparticles for cancer drug delivery Journal of Colloids and Interface Science 360 2011 39 51
36. K.B. Senior Nano-dumpling with drug delivery potential Molecular Medicine Today 4 1998 321
37. K.S. Snima, R. Jayakumar, A.G. Unnikrishnan, S.V. Nair, and V.K. Lakshmanan O-carboxymethyl chitosan nanoparticles for metformin delivery to pancreatic cancer cells Carbohydrate Polymers 89 2012 1003 1007
38. K. Ulbrich, and V. Subr Polymeric anticancer drugs with pH-controlled activation Advanced Drug Delivery Reviews 56 2004 1023 1050
39. B. Vincenzi, G. Schiavon, M. Silletta, D. Santini, and G. Tonini The biological properties of cetuximab Critical Reviews in Oncology/Hematology 68 2008 93 106
40. T. Wang, H. Wang, and Y. Soong Paclitaxel induced cell death Cancer 88 2000 2619 2628
41. C. Zielinski Potential of biologically targeted therapies for breast cancer EJC Supplements 4 2006 23 26